Biocryst Pharmaceuticals BCRX
NASDAQ BCRX
$8.09 -0.24 (-2.88%)
As of: Oct 1, 2026 · 3:51 PM EDT

Biocryst Pharmaceuticals (BCRX) Change in Receivables (2010 - 2026)

Updated

Biocryst Pharmaceuticals (BCRX) reported Change in Receivables of $1.49 million for Q2 2026, down 79.7% from $7.31 million a year earlier but up 213.3% from the prior quarter.

Analysis

Biocryst Pharmaceuticals (BCRX) Change in Receivables (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Biocryst Pharmaceuticals' Change in Receivables came in at $17.47 million, down 45.2% year-over-year; for FY2025, it came in at $36.81 million, up 62.2% from FY2024.

  • By year, Change in Receivables came in at $22.7 million in FY2024 (+272.4%), $6.1 million in FY2023 (-71.6%), $21.47 million in FY2022 (+3.1%) and $20.82 million in FY2021.
  • Five-year quarterly Change in Receivables spans a low of -$3.84 million in Q3 2023 and a high of $15.49 million in Q4 2025.
  • Year over year, Change in Receivables gained in three of the last seven quarters, with growth averaging 33.6%.
  • The high point for year-over-year Change in Receivables in five years was Q1 2025 (growth of 264.3%); the low point was Q3 2025 (a decline of 99.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $474,000 (Q1 2026), $15.49 million (Q4 2025) and $17,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.35 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.37 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.09 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 333.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 140.20 Mn
10 Biocryst Pharmaceuticals 2.13 Bn 1.05 Bn 214.41 Mn 1.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.49 Mn
Mar 31, 2026 474,000.00
Dec 31, 2025 15.49 Mn
Sep 30, 2025 17,000.00
Jun 30, 2025 7.31 Mn
Mar 31, 2025 13.99 Mn
Dec 31, 2024 7.30 Mn
Sep 30, 2024 3.32 Mn
Jun 30, 2024 8.25 Mn
Mar 31, 2024 3.84 Mn
Dec 31, 2023 2.97 Mn
Sep 30, 2023 -3.84 Mn
Jun 30, 2023 8.99 Mn
Mar 31, 2023 -2.02 Mn
Dec 31, 2022 7.64 Mn
Sep 30, 2022 1.48 Mn
Jun 30, 2022 5.30 Mn
Mar 31, 2022 7.05 Mn
Dec 31, 2021 3.24 Mn
Sep 30, 2021 -1.40 Mn
API Access

Biocryst Pharmaceuticals Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=BCRX&period=max&api_key=YOUR_API_KEY